Allium Medical Solutions Ltd. is a publicly traded company that offers innovative and minimally invasive medical products for treating a wide range of diseases. Their products are designed to improve the recovery process and shorten hospital stays for patients. The company's portfolio includes ProCatid, an embolic protection system for the carotid arteries, TruLeaf, a solution for mitral valve regurgitation, and Allevetix, a minimal invasive therapy for treating type 2 diabetes in obese and overweight patients. Allium Medical Solutions is headquartered in Caesarea, Israel, and its products are marketed worldwide.